CORRECTION: BioSig & Streamex Clarify and Correct Details of Russell Starr’s Appointment and Biography

Download as PDF

 

VANCOUVER, British Columbia & LOS ANGELES--(BUSINESS WIRE)-- BioSig Technologies, Inc. (“BioSig” or the “Company”), which recently merged with Streamex Exchange Corporation (“Streamex”) (Nasdaq: BSGM), issues a correction to the press release regarding the appointment of Russell Starr as Strategic Advisor to Streamex, published on July 11, 2025. The correction concerns a clarification in the press release with respect to stated aspects of Mr. Starr’s biography, including his most recent role and responsibilities at DeFi Technologies and that he led the Company’s growth from $0.07 USD to $4.95 USD per share and over $200M USD in yearly revenue. During this period, Mr. Starr was not the Chief Executive Officer of the Company, but instead served as Head of Capital Markets Consultant at DeFi Technologies. The corrected biography of Mr. Starr is set forth below. All other information in the press release on July 11, 2025 remains unchanged.

BioSig reiterates that Mr. Starr is a former executive on Bay Street and respected entrepreneur and financier, Mr. Starr has built a reputation for navigating high-stakes financial transactions and guiding companies through complex growth trajectories. Most recently, he was Head of Capital Markets Consultant at DeFi Technologies, a publicly traded company at the forefront of decentralized finance and digital asset innovation. During his time with DeFi Technologies, it accelerated its strategic focus on Web3 infrastructure, emerging markets, and tokenized finance. Mr. Starr also helped bring Defi Technologies to be listed on the Nasdaq.

Mr. Starr’s career is defined by a consistent focus on long-term value creation, particularly in the natural resource and renewable energy sectors. He is a strong advocate for Canada’s emerging leadership in the global resource economy and sees the convergence of the renewable energy transition and weakening fiat currencies as powerful tailwinds for real asset investment.

Over the course of his career, Mr. Starr has held key leadership roles across public and private companies, contributing deep expertise in M&A, venture capital, and strategic partnerships. His ability to structure high-return, high-impact deals has earned him the trust of stakeholders across sectors.

Forward-Looking Statements

This press release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements may be preceded by the words “intends,” “may,” “will,” “plans,” “expects,” “anticipates,” “projects,” “predicts,” “estimates,” “aims,” “believes,” “hopes,” “potential,” or similar words. Forward-looking statements are not guarantees of future performance, are based on certain assumptions, and are subject to various known and unknown risks and uncertainties, many of which are beyond our control. It is possible that our actual results and financial condition may differ, possibly materially, from the anticipated results and financial condition indicated in these forward-looking statements, depending on factors including whether we will be able to realize the benefits of the acquisition of Streamex, whether shareholder approval of the acquisition will be obtained, and whether we will be able to maintain compliance with Nasdaq’s listing criteria in connection with the acquisition and otherwise. For a discussion of other risks and uncertainties, and other important factors, any of which could cause our actual results to differ from those contained in forward-looking statements, see our filings with the Securities and Exchange Commission, including the section titled “Risk Factors” in our Annual Report on Form 10-K, filed with the SEC on April 15, 2025. We assume no obligation to publicly update or revise our forward-looking statements as a result of new information, future events or otherwise, except as required by law.

johanna@trailrunnerint.com

Source: BioSig Technologies, Inc.

Released July 11, 2025